Authors’ reply to comment on “effectiveness and tolerability of methylthioninium chloride (methylene blue) for the treatment of methemoglobinemia: twenty-four years of experience at a single poison center”
Open Access
- 10 September 2025
- journal article
- Published by Taylor & Francis in Clinical Toxicology
- Vol. 63 (10) , 799-800
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Effectiveness and tolerability of methylthioninium chloride (methylene blue) for the treatment of methemoglobinemia: twenty-four years of experience at a single poison centerClinical Toxicology, 2025
- Regional readiness for sodium nitrite-induced methemoglobinemia: availability of methemoglobin testing and methylthioninium chloride (methylene blue) stocking in the Upper Midwestern United StatesClinical Toxicology, 2025
- Massive Sodium Nitrite Overdose: A Case for Prehospital Methylene BluePrehospital Emergency Care, 2024
- A CASE OF RASBURICASE-INDUCED METHEMOGLOBINEMIA DUE TO GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY TREATED WITH HYPERBARIC OXYGEN THERAPYChest, 2019
- A Case of Methemoglobinemia Successfully Treated with Hyperbaric Oxygenation MonotherapyThe Journal of Emergency Medicine, 2017
- Exchange transfusion as treatment for rasburicase induced methemoglobinemia in a glucose‐6‐phosphate dehydrogenase deficient patientPediatric Blood & Cancer, 2008
- Treatment of high-risk, refractory acquired methemoglobinemia with automated red blood cell exchangeJournal of Clinical Apheresis, 1998